Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
long-acting injectable ivermectin / MedinCell
2021-001938-19: A MULTICENTRE CLINICAL STUDY TO EVALUATE THE EFFICACY ANDSAFETY OF IVERMECTIN IN PREVENTION OF COVID-19	Not yet recruiting	2	400	Europe	Ivermectine Substipharm 3mg, tablet, Tablet, Ivermectine Substipharm 3 mg, tablet	MedinCell S.A., MedinCell S.A.	Prophylaxis of COVID-19 infection, Prevention of COVID-19, Diseases [C] - Virus Diseases [C02]